Biomede
PrivateLast Round
VC Round
Oct 20, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biomede is an agtech company that provides phytoextraction solutions to remove heavy metals from agricultural soils using specialized plants.
Sector
Energy & Sustainability
Verticals
Biotechnology, Circular Economy, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomede Comparables
Compare Biomede with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phyona Ltd | 85% | |
| RemePhy Technologies | 78% | |
| Novobiom | 78% |
Biomede Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 20, 2022 | ||||
| Accelerator | Nov 1, 2018 | ||||
| Seed | Mar 22, 2018 |
Biomede Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 50 Partners | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 53% MoM.
- May 15, 2026
Monthly visitors grew 493% MoM.
Biomede Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomede's valuation, stock price, and market status.
Is Biomede a public or private company?
Biomede is a private company.
What is the current stock price of Biomede?
Biomede is a private company with no public stock price. No recent secondary market data is available.
How much is Biomede worth (valuation)?
Valuation information for Biomede is not publicly available.
Can I buy Biomede stock?
Biomede shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomede's last funding round?
Biomede's most recent funding round was VC Round on October 20, 2022.
Who are the main investors in Biomede?
Key investors in Biomede include 50 Partners.
Will Biomede IPO soon?
No public IPO plans have been announced for Biomede.
How can I track Biomede secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomede's secondary market activity and sign up for updates.